The success of ocular surgery, especially refractive surgery, hinges on the health of the ocular surface.
By paying attention to the ocular surface before surgery, addressing any observed abnormalities and implementing therapies to treat ocular surface disease (OSD), we can improve vision outcomes and patient satisfaction and help prevent postoperative complications.
A promising therapy for patients with OSD that accelerates recovery of ocular surface health and corneal nerve regeneration is cryopreserved amniotic membrane (CAM). CAM is a biologic corneal bandage designed to treat diseases of